Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP4 | P15090 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.37 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.36 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19296374 | 0.80 | CYP1A2 (0.39) | HDAC1FOLH1 | |
| SCHEMBL18623460 | 0.79 | L3MBTL1 (0.44) | L3MBTL1HRH4HRH3 | |
| SCHEMBL25836729 | 0.79 | SRC (0.38) | FABP4HSP90AB1L3MBTL1 | |
| SCHEMBL24665771 | 0.76 | CYP19A1 (0.60) | HDAC1HSP90AB1HRH4 | |
| SCHEMBL22059619 | 0.75 | NR1H4 (0.44) | FABP4HDAC1FOLH1HRH4HRH3 | |
| SCHEMBL22060200 | 0.75 | NAMPT (0.42) | FOLH1HRH4HRH3 | |
| SCHEMBL2628207 | 0.74 | CYP4F2 (0.40) | FOLH1HSP90AB1ALOX5 | |
| SCHEMBL18605543 | 0.74 | CYP4F2 (0.40) | FOLH1HSP90AB1ALOX5 | |
| SCHEMBL9914065 | 0.73 | BRD4 (0.39) | FABP4L3MBTL1 | |
| SCHEMBL15803295 | 0.73 | HDAC1 (0.58) | HDAC1HSP90AB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120100073-A1 | PET RADIOTRACERS FOR IMAGING FATTY ACID METABOLISM AND STORAGE | WASHINGTON UNIVERSITY (US) | 2012-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120100073-A1 | PET RADIOTRACERS FOR IMAGING FATTY ACID METABOLISM AND STORAGE | LIPC, PNLIP, FFAR1 | FABP4 5/4885HDAC1 3094/4885FOLH1 488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.